Active, Not Recruiting
A Phase 1 First-In-Human Study of the Anti-CD73 IPH5301 Alone or in Combination With Chemotherapy and Trastuzumab in Patients With Advanced Solid Tumors
NCT05143970
- Conditions
- Adnexal Diseases, Advanced Solid Tumor, Breast Diseases, +48 more
- Locations
-
- Institut Paoli Calmettes Marseille, France